Cargando…
In Silico Identification of a BRCA1:miR-29:DNMT3 Axis Involved in the Control of Hormone Receptors in BRCA1-Associated Breast Cancers
Germline inactivating mutations in the BRCA1 gene lead to an increased lifetime risk of ovarian and breast cancer (BC). Most BRCA1-associated BC are triple-negative tumors (TNBC), aggressive forms of BC characterized by a lack of expression of estrogen and progesterone hormone receptors (HR) and HER...
Autores principales: | Santarosa, Manuela, Baldazzi, Davide, Armellin, Michela, Maestro, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298721/ https://www.ncbi.nlm.nih.gov/pubmed/37373065 http://dx.doi.org/10.3390/ijms24129916 |
Ejemplares similares
-
Mesenchymal traits are selected along with stem features in breast cancer cells grown as mammospheres
por: Borgna, Silvia, et al.
Publicado: (2012) -
A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness
por: di Gennaro, Alessandra, et al.
Publicado: (2018) -
An improved sequencing-based strategy to estimate locus-specific DNA methylation
por: Brisotto, Giulia, et al.
Publicado: (2015) -
In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing
por: Poon, Kok-Siong
Publicado: (2021) -
Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers
por: Depypere, Herman, et al.
Publicado: (2021)